312 related articles for article (PubMed ID: 25194457)
1. Effects of aldosterone on insulin sensitivity and secretion.
Luther JM
Steroids; 2014 Dec; 91():54-60. PubMed ID: 25194457
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.
Luther JM; Luo P; Kreger MT; Brissova M; Dai C; Whitfield TT; Kim HS; Wasserman DH; Powers AC; Brown NJ
Diabetologia; 2011 Aug; 54(8):2152-63. PubMed ID: 21519965
[TBL] [Abstract][Full Text] [Related]
3. Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.
Adler GK; Murray GR; Turcu AF; Nian H; Yu C; Solorzano CC; Manning R; Peng D; Luther JM
Hypertension; 2020 May; 75(5):1251-1259. PubMed ID: 32172621
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
5. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
Sowers JR; Whaley-Connell A; Epstein M
Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
[TBL] [Abstract][Full Text] [Related]
6. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
[TBL] [Abstract][Full Text] [Related]
7. Secondary diabetes mellitus due to primary aldosteronism.
Moustaki M; Paschou SA; Vakali EC; Vryonidou A
Endocrine; 2023 Jan; 79(1):17-30. PubMed ID: 36001240
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Bender SB; McGraw AP; Jaffe IZ; Sowers JR
Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
[TBL] [Abstract][Full Text] [Related]
9. Dietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humans.
Luther JM; Byrne LM; Yu C; Wang TJ; Brown NJ
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1895-902. PubMed ID: 25029426
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system and glucose homeostasis.
Luther JM; Brown NJ
Trends Pharmacol Sci; 2011 Dec; 32(12):734-9. PubMed ID: 21880378
[TBL] [Abstract][Full Text] [Related]
12. A possible association between primary aldosteronism and a lower beta-cell function.
Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
[TBL] [Abstract][Full Text] [Related]
13. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.
Jia G; Lockette W; Sowers JR
Am J Physiol Regul Integr Comp Physiol; 2021 Mar; 320(3):R276-R286. PubMed ID: 33438511
[TBL] [Abstract][Full Text] [Related]
15. Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.
Sindelka G; Widimský J; Haas T; Prázný M; Hilgertová J; Skrha J
Exp Clin Endocrinol Diabetes; 2000; 108(1):21-5. PubMed ID: 10768828
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of insulin sensitivity and secretion in primary aldosteronism.
Watanabe D; Yatabe M; Ichihara A
Clin Exp Hypertens; 2016; 38(7):613-617. PubMed ID: 27669369
[TBL] [Abstract][Full Text] [Related]
17. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
Jing F; Mogi M; Horiuchi M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
[TBL] [Abstract][Full Text] [Related]
18. Potassium as a link between insulin and the renin-angiotensin-aldosterone system.
Ferrannini E; Galvan AQ; Santoro D; Natali A
J Hypertens Suppl; 1992 Apr; 10(1):S5-10. PubMed ID: 1619503
[TBL] [Abstract][Full Text] [Related]
19. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.
Lastra G; Whaley-Connell A; Manrique C; Habibi J; Gutweiler AA; Appesh L; Hayden MR; Wei Y; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E110-6. PubMed ID: 18445755
[TBL] [Abstract][Full Text] [Related]
20. This is not Dr. Conn's aldosterone anymore.
Brown NJ
Trans Am Clin Climatol Assoc; 2011; 122():229-43. PubMed ID: 21686229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
